ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Exogenous Estrogen in Men
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="testiculus" data-source="post: 140254" data-attributes="member: 17128"><p>Old study that looked at exogenous estrogen (among other things) in men targeted at reducing mortality due to cardiac events:</p><p></p><p><a href="https://www.popline.org/node/510398" target="_blank">The Coronary Drug Project: findings leading to discontinuation of the 2.5-mg/day estrogen group.</a></p><p></p><p>The purpose of the Coronary Drug Project, a national collaborative study, is to evaluate long-term effects of several drug regimens influencing lipid metabolism, compared with placebo, in men originally aged 30-64 years who had recovered from 1 or more episodes of myocardial infarction. 53 clinical centers recruited 8341 patients from 1966-1969; the men were randomly assigned to the project's 6 groups. 2 of the study regimens - 5.0 mg/day of estrogen (ESG2) and 6.0 mg/day of dextrothyroxine (DT4) were discontinued in 1970 and 1971, respectively, due to trends indicative of adverse effects. As of February 1, 1973, with an average followup of 56 months, data on the 2.5 mg/day estrogen group (ESG1) indicated no evidence of an overall positive therapeutic effect in terms of the project's primary end point, mortality from all causes.</p></blockquote><p></p>
[QUOTE="testiculus, post: 140254, member: 17128"] Old study that looked at exogenous estrogen (among other things) in men targeted at reducing mortality due to cardiac events: [URL='https://www.popline.org/node/510398']The Coronary Drug Project: findings leading to discontinuation of the 2.5-mg/day estrogen group.[/URL] The purpose of the Coronary Drug Project, a national collaborative study, is to evaluate long-term effects of several drug regimens influencing lipid metabolism, compared with placebo, in men originally aged 30-64 years who had recovered from 1 or more episodes of myocardial infarction. 53 clinical centers recruited 8341 patients from 1966-1969; the men were randomly assigned to the project's 6 groups. 2 of the study regimens - 5.0 mg/day of estrogen (ESG2) and 6.0 mg/day of dextrothyroxine (DT4) were discontinued in 1970 and 1971, respectively, due to trends indicative of adverse effects. As of February 1, 1973, with an average followup of 56 months, data on the 2.5 mg/day estrogen group (ESG1) indicated no evidence of an overall positive therapeutic effect in terms of the project's primary end point, mortality from all causes. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Exogenous Estrogen in Men
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top